EP4275749A3 - Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy - Google Patents
Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy Download PDFInfo
- Publication number
- EP4275749A3 EP4275749A3 EP23177475.3A EP23177475A EP4275749A3 EP 4275749 A3 EP4275749 A3 EP 4275749A3 EP 23177475 A EP23177475 A EP 23177475A EP 4275749 A3 EP4275749 A3 EP 4275749A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- chemotherapy
- neuropathic pain
- pain associated
- peripheral neuropathy
- treating neuropathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002512 chemotherapy Methods 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 208000033808 peripheral neuropathy Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Dermatology (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
The invention features methods of preventing and/or treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy (CIPN).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192246P | 2021-05-24 | 2021-05-24 | |
| EP22730040.7A EP4114403B1 (en) | 2021-05-24 | 2022-05-23 | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
| PCT/US2022/072496 WO2022251805A1 (en) | 2021-05-24 | 2022-05-23 | Treating pain associated with chemotherapy-induced peripheral neuropathy |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22730040.7A Division EP4114403B1 (en) | 2021-05-24 | 2022-05-23 | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4275749A2 EP4275749A2 (en) | 2023-11-15 |
| EP4275749A3 true EP4275749A3 (en) | 2024-01-03 |
Family
ID=82019337
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22730040.7A Active EP4114403B1 (en) | 2021-05-24 | 2022-05-23 | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
| EP23177475.3A Pending EP4275749A3 (en) | 2021-05-24 | 2022-05-23 | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22730040.7A Active EP4114403B1 (en) | 2021-05-24 | 2022-05-23 | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP4114403B1 (en) |
| JP (1) | JP2024520463A (en) |
| KR (1) | KR20240013092A (en) |
| CN (1) | CN117377476A (en) |
| AU (1) | AU2022283458A1 (en) |
| BR (1) | BR112023024422A2 (en) |
| CA (1) | CA3220195A1 (en) |
| DK (1) | DK4114403T3 (en) |
| ES (1) | ES2952672T3 (en) |
| FI (1) | FI4114403T3 (en) |
| HR (1) | HRP20230541T1 (en) |
| HU (1) | HUE062891T2 (en) |
| LT (1) | LT4114403T (en) |
| MA (1) | MA58889B1 (en) |
| PL (1) | PL4114403T3 (en) |
| PT (1) | PT4114403T (en) |
| RS (1) | RS64471B1 (en) |
| SI (1) | SI4114403T1 (en) |
| WO (1) | WO2022251805A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130225529A1 (en) * | 2012-02-27 | 2013-08-29 | Basil Rigas | Phospho-ester derivatives and uses thereof |
| WO2018064354A1 (en) * | 2016-09-28 | 2018-04-05 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2618482T3 (en) | 2007-08-10 | 2017-06-21 | Basil Rigas | Anti-inflammatory compounds and uses thereof |
| EP3687524A4 (en) | 2017-09-28 | 2021-06-09 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
-
2022
- 2022-05-23 EP EP22730040.7A patent/EP4114403B1/en active Active
- 2022-05-23 CN CN202280037433.7A patent/CN117377476A/en active Pending
- 2022-05-23 BR BR112023024422A patent/BR112023024422A2/en unknown
- 2022-05-23 SI SI202230002T patent/SI4114403T1/en unknown
- 2022-05-23 EP EP23177475.3A patent/EP4275749A3/en active Pending
- 2022-05-23 LT LTEPPCT/US2022/072496T patent/LT4114403T/en unknown
- 2022-05-23 PL PL22730040.7T patent/PL4114403T3/en unknown
- 2022-05-23 FI FIEP22730040.7T patent/FI4114403T3/en active
- 2022-05-23 PT PT227300407T patent/PT4114403T/en unknown
- 2022-05-23 ES ES22730040T patent/ES2952672T3/en active Active
- 2022-05-23 JP JP2023572970A patent/JP2024520463A/en active Pending
- 2022-05-23 HR HRP20230541TT patent/HRP20230541T1/en unknown
- 2022-05-23 RS RS20230459A patent/RS64471B1/en unknown
- 2022-05-23 KR KR1020237034666A patent/KR20240013092A/en unknown
- 2022-05-23 CA CA3220195A patent/CA3220195A1/en active Pending
- 2022-05-23 MA MA58889A patent/MA58889B1/en unknown
- 2022-05-23 WO PCT/US2022/072496 patent/WO2022251805A1/en active Application Filing
- 2022-05-23 DK DK22730040.7T patent/DK4114403T3/en active
- 2022-05-23 HU HUE22730040A patent/HUE062891T2/en unknown
- 2022-05-23 AU AU2022283458A patent/AU2022283458A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130225529A1 (en) * | 2012-02-27 | 2013-08-29 | Basil Rigas | Phospho-ester derivatives and uses thereof |
| WO2018064354A1 (en) * | 2016-09-28 | 2018-04-05 | Medicon Pharmaceuticals, Inc. | Compositions and methods for treating ophthalmic conditions |
Non-Patent Citations (2)
| Title |
|---|
| ARGYRIOU ANDREAS A ET AL: "Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 112, no. 5, 1 September 2008 (2008-09-01), pages 1593 - 1599, XP002594460, ISSN: 0006-4971, [retrieved on 20080623], DOI: 10.1182/BLOOD-2008-04-149385 * |
| THOMAS J KALEY ET AL: "Therapy of chemotherapy-induced peripheral neuropathy", BRITISH JOURNAL OF HAEMATOLOGY, JOHN WILEY, HOBOKEN, USA, vol. 145, no. 1, 20 January 2009 (2009-01-20), pages 3 - 14, XP071104838, ISSN: 0007-1048, DOI: 10.1111/J.1365-2141.2008.07558.X * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022283458A1 (en) | 2024-01-18 |
| PL4114403T3 (en) | 2023-10-09 |
| DK4114403T3 (en) | 2023-07-24 |
| EP4275749A2 (en) | 2023-11-15 |
| EP4114403A1 (en) | 2023-01-11 |
| CN117377476A (en) | 2024-01-09 |
| MA58889B1 (en) | 2023-06-28 |
| CA3220195A1 (en) | 2022-12-01 |
| HRP20230541T1 (en) | 2023-09-29 |
| ES2952672T3 (en) | 2023-11-03 |
| FI4114403T3 (en) | 2023-07-27 |
| JP2024520463A (en) | 2024-05-24 |
| BR112023024422A2 (en) | 2024-02-20 |
| SI4114403T1 (en) | 2023-10-30 |
| EP4114403B1 (en) | 2023-06-07 |
| LT4114403T (en) | 2023-09-25 |
| WO2022251805A1 (en) | 2022-12-01 |
| RS64471B1 (en) | 2023-09-29 |
| KR20240013092A (en) | 2024-01-30 |
| PT4114403T (en) | 2023-08-17 |
| HUE062891T2 (en) | 2023-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3476319A3 (en) | Implant with intramedullary portion and offset extramedullary portion | |
| EP3298972A3 (en) | Systems for intramedullary nail implantation | |
| EP2362224A3 (en) | Blood group antigens of different types for diagnostic and therapeutic applications | |
| EP1990059A3 (en) | methods for treating cancer | |
| EP3159018A3 (en) | Gradient coating for biomedical applications | |
| EP2993165A3 (en) | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof | |
| EP2468776A3 (en) | Anti-Robo4 antibodies and uses therefor | |
| EP3351558A3 (en) | Material and methods for treating or preventing her-3 associated diseases | |
| EP4338804A3 (en) | Epinephrine spray formulations | |
| EP3747371A3 (en) | Dental retraction device | |
| EP1607038A3 (en) | Endoscope apparatus | |
| EP3825049A3 (en) | Adjustable featherboard | |
| EP4234560A3 (en) | Antiviral prodrugs and nanoformulations thereof | |
| EP4194715A3 (en) | High reduction belt-driven linear actuator | |
| EP3804638A3 (en) | Percutaneous access pathway system | |
| WO2021004958A3 (en) | Compositions comprising bacterial strains | |
| EP3378503A3 (en) | Calcium based clinical material with antimicrobial properties and method of forming for prevention or treatment of infection | |
| EP4275749A3 (en) | Treating neuropathic pain associated with chemotherapy-induced peripheral neuropathy | |
| EP4316539A3 (en) | Medical device with hydrophilic coating | |
| EP4105237A4 (en) | Cldn18.2 antibody and use thereof | |
| EP4272826A3 (en) | Treating pain associated with diabetic peripheral neuropathy | |
| EP4268822A3 (en) | Compositions for treating vascular ehlers danlos syndrome | |
| WO2023235838A3 (en) | Rna-targeting splicing modifiers for treatment of foxp3-associated conditions and diseases | |
| EP2050475A3 (en) | Medical devices incorporating radio-opaque and biocompatible coatings | |
| EP4233963A3 (en) | Implantable medical device delivery systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
| AC | Divisional application: reference to earlier application |
Ref document number: 4114403 Country of ref document: EP Kind code of ref document: P |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61P0025020000 Ipc: A61K0031661000 |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/02 20060101ALI20231127BHEP Ipc: A61K 31/661 20060101AFI20231127BHEP |